BioWorld Asia

Jan. 20, 2010

BioInvent to Get $21M in Directed Share Offer with Little Discount

BioInvent International AB is pocketing around SEK150 million (US$21.2 million) - before expenses - and making two prominent additions to its shareholders' register, via a directed offering of 5,434,800 shares. Read More

Comments from EU Health Chief Designate Has Industry on Edge

Wellcome Trust Offers Bonanza of Sequencing, Genome Data

BioMedPartners Closes $102M Fund for Early- Mid-Stage EU Companies

U.S. Scientific Inventory Shows Asia, EU Gaining in R&D Status

40 UK Companies Will Share in £8.3M Stem Cell Program

Rapid U.S. Biomedical Research Funding Is Dead: JAMA Report

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for July 2, 2026.

AI-generated image for brain organoid neural research

CINP 2026: organoids reveal autism and addiction mechanisms

BioWorld Science

At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...

CINP 2026: Prenatal and adolescent stress shape brain vulnerability

BioWorld Science

Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...

Ontrack Therapeutics divulges compounds for neurodegenerative diseases

BioWorld Science

Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.

Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists

BioWorld Science

Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...